Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trio-Tech International (TRT) Research & Development (2016 - 2025)

Trio-Tech International (TRT) has disclosed Research & Development for 16 consecutive years, with $106000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development fell 7.02% to $106000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $382000.0, a 1.06% increase, with the full-year FY2025 number at $384000.0, down 2.04% from a year prior.
  • Research & Development was $106000.0 for Q4 2025 at Trio-Tech International, up from $94000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $151000.0 in Q4 2022 to a low of $73000.0 in Q3 2022.
  • A 5-year average of $95350.0 and a median of $87500.0 in 2023 define the central range for Research & Development.
  • Biggest YoY gain for Research & Development was 16.44% in 2023; the steepest drop was 13.25% in 2023.
  • Trio-Tech International's Research & Development stood at $131000.0 in 2021, then grew by 15.27% to $151000.0 in 2022, then decreased by 13.25% to $131000.0 in 2023, then fell by 12.98% to $114000.0 in 2024, then dropped by 7.02% to $106000.0 in 2025.
  • Per Business Quant, the three most recent readings for TRT's Research & Development are $106000.0 (Q4 2025), $94000.0 (Q3 2025), and $92000.0 (Q2 2025).